| Article ID | Journal | Published Year | Pages | File Type | 
|---|---|---|---|---|
| 8459140 | Radiotherapy and Oncology | 2018 | 8 Pages | 
Abstract
												BT has favorable cosmesis over EBRT for skin SCCs/BCCs at common fractionation regimens. Prospective studies comparing EBRT vs BT are warranted.
											Keywords
												
											Related Topics
												
													Life Sciences
													Biochemistry, Genetics and Molecular Biology
													Cancer Research
												
											Authors
												Nicholas G. Zaorsky, Charles T. Lee, Eddie Zhang, Thomas J. Galloway, 
											